- Overview
- Product Description
- Detailed Photos
- Company Profile
- Certifications
- Our Advantages
Basic Info.
Model NO.
2000ml-2500ml
State
Liquid
Type
Inorganic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Transport Package
Carton
Specification
2000ml: 2.5Glucose
Trademark
Huaren
Origin
China
Product Description
Drug name :Peritoneal dialysate (lactate)
Character:This product is a colorless or slightly yellow clear liquid
Indications:
This product is suitable for patients with acute and chronic renal failure who require continuous ambulatory peritoneal dialysis and continuous cyclic peritoneal dialysis due to ineffective non-dialysis treatment..
Specifications:
| Peritoneal dialysate (lactate) | 1.5% Glucose:2000ml | Non PVC soft bags |
| 1.5% Glucose:2500ml | Non PVC soft bags | |
| 2.5% Glucose:2000ml | Non PVC soft bags | |
| 2.5% Glucose:2500ml | Non PVC soft bags | |
| Peritoneal Dialysate (lactate G4.25%) | 2L/bag | PP (non PVC co-extruded film/double hose/double valve and double plug) |
| Peritoneal Dialysate (lactate G4.25%) | 2.5L/bag | PP (non PVC co-extruded film/double hose/double valve and double plug) |
Founded in May 1998, Huaren Pharmaceutical is a modern pharmaceutical and health industry group integrating R&D, production and sales, focusing on medicine, health, medical equipment and medical services.
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
Pharmaceutical packaging materials,Rubber stoppers and APIs are self-produced and self-sold, the price is lower and the quality is more guaranteed.